Title:
Method to guide optimal therapy choice in breast cancer
Location:Finland
Ref no:09 FI 30I0 3DFA
Rating:
Abstract
Finnish central hospital researchers have identified a biomarker which can be used to guide optimal therapy choice in breast cancer. This finding is a base for creation novel diagnostic tests for personalized medicine applications and patient care in treatment for breast cancer. Diagnostics companies are sought for license and further development.
Details
>> To find out more about the opportunity login or register for C2i.
|